Remissio UG

Startup

At Remissio we use AI to design immunotherapy, exciting new cancer treatment that modified you immune cells to fight cancer. This promising therapy is available for less than 1 % of patients because of dangerous side effects damage healthy cells and prevent wide adoption of this therapy.  We solve the problem of side effects by building an AI software that predicts them at an early stage of drug testing and allows a cost-effective development of safe therapy.



website